{
    "abstractText": "Phytochemical investigation of the leaves of Polyscias Australiana (F.Muell.) Philipson (family Araliaceae) led to the isolation and identification of two new analogues belonging to the rare dammarane-type triterpene glycosides, polysciasosides B (1) and C (2). Also isolated in high yields from this plant was the known saponin, \u03b2-hedrin (3). The two new polysciasoside analogues exhibited no antiinflammatory activity (inhibitory effects on NO inhibition and cell viability in RAW 264.7 macrophages) or cytotoxic activity against AGS gastric adenocarcinoma or the MCF7 breast adenocarcinoma cell lines. In contrast, the known compound \u03b2-hedrin exhibited potent anti-inflammatory and cytotoxicity in these biological assays.",
    "authors": [
        {
            "affiliations": [],
            "name": "Ritesh Raju"
        },
        {
            "affiliations": [],
            "name": "Paayal Kumar"
        },
        {
            "affiliations": [],
            "name": "Radwa A. Eladwy"
        },
        {
            "affiliations": [],
            "name": "Deep Bhuyan"
        },
        {
            "affiliations": [],
            "name": "Paul Reddell"
        },
        {
            "affiliations": [],
            "name": "Gerald M\u00fcnch"
        }
    ],
    "id": "SP:a3cd97c15db396446ccf15544296a4916727ffb0",
    "references": [],
    "sections": [
        {
            "text": "Phytochemical investigation of the leaves of Polyscias Australiana (F.Muell.) Philipson (family Araliaceae) led to the isolation and\nidentification of two new analogues belonging to the rare dammarane-type triterpene glycosides, polysciasosides B (1) and C (2). Also\nisolated in high yields from this plant was the known saponin, \u03b2-hedrin (3). The two new polysciasoside analogues exhibited no anti-\ninflammatory activity (inhibitory effects on NO inhibition and cell viability in RAW 264.7 macrophages) or cytotoxic activity against\nAGS gastric adenocarcinoma or the MCF7 breast adenocarcinoma cell lines. In contrast, the known compound \u03b2-hedrin exhibited potent\nanti-inflammatory and cytotoxicity in these biological assays.\nKeywords: Cytotoxicity; dammarane; triterpene; Polyscias Australiana; anti-inflammatory; Araliaceae\nTable S1. NMR data (600 MHz, MeOH-d4) for polysciasoside B (1) .......................................................................... 3 Table S2. NMR data (600 MHz, MeOH-d4) for polysciasoside C (2) .......................................................................... 4 Table S3. In vitro anti-inflammatory activity of compounds 1 \u2013 3 in LPS + IFN-\u03b3 activated RAW 264.7 macrophages ....5 Table S4. Cell growth inhibition (%) of (1), (2), and (3) against AGS gastric and MCF7 breast adenocarcinoma cells .....5 Figure S1. 1H NMR spectrum (600 MHz, MeOH-d4) for polysciasoside B (1) ............................................................... 6 Figure S2. COSY spectrum (600 MHz, MeOH-d4) for polysciasoside B (1) ................................................................... 7 Figure S3. HSQC spectrum (600 MHz, MeOH-d4) for polysciasoside B (1) ................................................................... 8 Figure S4. HMBC spectrum (600 MHz, MeOH-d4) for polysciasoside B (1) .................................................................. 9 Figure S5. NOESY spectrum (600 MHz, MeOH-d4) for polysciasoside B (1) ................................................................. 10 Figure S6. Selective NOESY spectrum at 1.32ppm (H-18) showing correlations to H-13, H-19 and H-15 (600 MHz, MeOH-d4) for polysciasoside B (1) ........................................................................................................... 11 Figure S7. Selective NOESY spectrum at 0.99ppm (H-19) showing correlations to H-29 and H-18 (600 MHz, MeOH-d4) for polysciasoside B (1) ....................................................................................................................12 Figure S8. 1H NMR spectrum (600 MHz, MeOH-d4) for polysciasoside C (2) ............................................................... 13 Figure S9. COSY spectrum (600 MHz, MeOH-d4) for polysciasoside C (2) ................................................................... 14 Figure S10. HSQC spectrum (600 MHz, MeOH-d4) for polysciasoside C (2) ................................................................. 15 Figure S11. HMBC spectrum (600 MHz, MeOH-d4) for polysciasoside C (2) ................................................................ 16 Figure S12. NOESY spectrum (600 MHz, MeOH-d4) for polysciasoside C (2) ............................................................... 17 Figure S13. 1H NMR spectrum (600 MHz, MeOH-d4) for \u03b2-hedrin (3) ......................................................................... 18 Figure S14. HRMS spectrum for polysciasoside B (1) ................................................................................................ 19 Figure S15. HRMS spectrum for polysciasoside C (2) ................................................................................................ 20 Figure S16. HRMS spectrum for oleanolic acid 3-O-L-rhamopyranosyl(1\u21922)-\u03b1-L-arabinopyranoside (3)........................21 Figure S17. Key 2D NMR correlations (600 MHz, MeOH-d4) for polysciasosides B (1) and C (2) .......................................22 Figure S18. Key NOESY correlations (600 MHz, MeOH-d4) for polysciasosides B (1) and C (2) .........................................23 Figure S19. HPLC trace (250nm) of the tolylthiocarbamoyl thiazolidine derivative of the standard sugar (D-glucose) ...24 Figure S20. HPLC trace (250nm) of the tolylthiocarbamoyl thiazolidine derivative of acid hydrolyzed polysciasoside C (2)...................................................................................................................................25\nTable S1. NMR data (600 MHz, MeOH-d4) for polysciasoside B (1)\nPos H (ppm) mult, (J in Hz) C* (ppm) COSY NOESY HMBC\n1 1.00 m, 1.56a m 39.8 2 2 1.69 m, 1.98 m 26.8 1, 3 3 3.17, m 90.1 2 5, 28 4 40.1 5 0.82 m 57.1 6 3, 9 6 1.55a m, 1.63 m 19.1 5, 7 7 1.54a m, 1.73b m 35.6 6 8 42.1 9 1.72b m 56.2 11 5, 30\n10 38.5 11 2.15 dd, (12.9, 3.7), 2.34c m 40.1 9 9, 12 12 214.4 13 3.03 d, (9.7) 54.8 17 15, 18 12, 14, 17, 20, 30 14 57.4 15 4.30 d, (8.5) 73.6 16 13, 18 8, 14, 16, 30 16 1.54a m, 1.99 m 33.5 15, 17 17 2.32c m 40.8 13, 16 21 18 1.32 s 15.8 13, 15, 19 7, 8, 9, 14 19 0.99 s 16.6 18, 29 1, 5, 9, 10 20 74.4 21 0.95 s 25.1 17 17, 20, 22 22 1.40 m 42.2 23 17, 20, 21, 23, 24 23 2.00, m 23.7 22, 24 20, 22, 24, 25 24 5.10 t, (7.1) 125.6 23 22, 23, 26, 27 25 132.1 26 1.67 s 25.6 24, 25,27 27 1.62 s 17.5 24, 25, 26 28 1.06 s 28.0 3 3, 4, 5, 29 29 30 1\u00b4 0.87 s 0.80 s 4.32 d (7.9) 16.5 10.8 106.5 2\u00b4 19 9 3\u00b4 3, 4, 5, 28 8, 13, 14, 15\n3, 2\u00b4, 5\u00b4 2\u00b4 3.19 dd (9.0, 7.9) 75.4 1\u00b4, 3\u00b4 1\u00b4 3\u00b4 3.33, m 78.2 2\u00b4, 4\u00b4 1\u00b4 2\u00b4, 4\u00b4 4\u00b4 3.28 dd (9.4, 8.7) 71.5 3\u00b4, 5\u00b4 5\u00b4, 6\u00b4 5\u00b4 3.25 m 77.5 4\u00b4, 6\u00b4 6\u00b4 3.84 dd, (12.0, 2.3), 3.66 dd, (12.0, 5.3) 62.6 5\u00b4 4\u00b4, 5\u00b4\n*assignments supported by HSQC and HMBC experiments, a-coverlapped resonances\nTable S2. NMR data (600 MHz, MeOH-d4) for polysciasoside C (2) Pos H (ppm) mult, (J in Hz) C* (ppm) COSY NOESY HMBC\n1 0.98 m, 1.53a m 39.5 2 2 1.69 m, 1.98 m 26.8 1, 3 3 3.17 dd (11.8, 4.4) 90.1 2 5 ,28 4, 28, 29 4 40.2 5 0.82 brd (11.3) 57.2 6 3, 9 6 1.56a m, 1.65 m 19.2 5, 7 7 1.35 m, 1.56a m 35.2 6 8 41.5 9 1.77 dd (13.3, 3.8) 55.3 11 5\n10 38.3 11 2.15 dd (13.3, 3.9), 2.34 dd (13.3, 13.1) 40.4 9 8, 9, 12 12 214.3 13 3.13 d (10.7) 57.2 17 18 8, 12, 14, 16, 17, 20, 30 14 55.8 15 1.26 d (13.2) 2.09b m 43.1 13, 16, 30 16 4.35 m 73.9 14, 20 17 2.30 dd (10.5, 4.4) 54.8 13, 16 21 18 1.19, s 16.2 13 7, 8, 9, 14 19 0.96, s 16.5 1, 5, 9, 10 20 74.1 21 1.04, s 26.1 17 17, 20, 22 22 1.55a m 42.0 23 23 2.11b, m 23.7 22, 24 24, 25 24 5.12, t (7.2) 125.9 23 23, 26, 27 25 131.8 26 1.66, s 25.7 24, 25, 27 27 1.62, s 17.6 24, 25, 26 28 1.06, s 28.3 3, 1\u00b4 3, 4, 5, 29 29 30 1\u00b4 0.87, s 1.00, s 4.34 d (7.8) 16.6 18.1 106.6 2\u00b4 28 3, 4, 5, 28 8, 13, 14, 15\n3, 5\u00b4 2\u00b4 3.21 dd (9.0, 7.9) 75.4 1\u00b4, 3\u00b4 1\u00b4, 3\u00b4 3\u00b4 3.37 dd (9.0, 8.9) 78.2 2\u00b4, 4\u00b4 2\u00b4, 4\u00b4, 5\u00b4 4\u00b4 3.31c 71.5 3\u00b4, 5\u00b4 3\u00b4, 6\u00b4 5\u00b4 3.27 m 77.5 4\u00b4, 6\u00b4 6\u00b4 3.87 dd (11.9, 2.3), 3.69 dd (11.9, 5.5) 62.6 5\u00b4 4\u00b4, 5\u00b4\n*assignments supported by HSQC and HMBC experiments, a-boverlapped resonances; cobscured by MeOH signal\nTable S3. In vitro anti-inflammatory activity of compounds 1 \u2013 3 in LPS + IFN-\u03b3 activated RAW 264.7 macrophages\nCompound Inhibition of NO Production (\u03bcg/mL) Cell viability (\u03bcg/mL) Inhibition of TNF-\u03b1 Production (\u03bcg/mL)\n1 >100 >100 NT 2 >100 >100 NT\n\u03b2 -hedrin (3) 0.85 \u00b1 0.1 1.29 \u00b1 0.1 1.64 \u00b1 0.3 Curcumin 4.64 \u00b1 1.5 10.86 \u00b1 1.3 4.19 \u00b1 2.6\nTable S4. Cell growth inhibition (%) of (1), (2), and (3) against the AGS gastric and MCF-7 breast adenocarcinoma cells.\nCell line Concentration (\u00b5g/mL) Cell growth inhibition (%)\n1 2 3\nAGS 100 18.41 \u00b1 12.81 24.17 \u00b1 12.20 103.64 \u00b1 0.61 50 NI NI 103.04\u00b1 0.79\n25 NI NI 87.70\u00b1 6.86 12.5 NI NI 79.93 \u00b1 4.20 6.25 NI NI 39.54 \u00b1 14.49 3.125 NI NI 4.93 \u00b1 3.55 IC50 >100 \u00b5g mL-1 >100 \u00b5g mL-1 8.38 \u00b1 1.79 \u00b5g mL-1\nMCF7 100 11.32 \u00b1 7.72 18.20 \u00b1 8.51 102.95 \u00b1 0.95 50 NI 0.47 \u00b1 8.29 102.44 \u00b1 1.13 25 NI NI 56.35 \u00b1 8.65 12.5 NI NI 1.32 \u00b1 7.72 6.25 NI NI NI 3.125 NI NI NI IC50 >100 \u00b5g mL-1 >100 \u00b5g mL-1 21.45 \u00b1 0.57 \u00b5g mL-1\nThe values for cell growth inhibition (%) presented are means \u00b1 standard deviations. NI = no cell growth inhibition detected. The IC50 (\u00b5g mL-1) is the concentration that inhibits cell growth by 50% using the Alamar blue assay after 72 h of treatment.\nFigure S1. 1H NMR spectrum (600 MHz, MeOH-d4) for polysciasoside B (1)\nFigure S2. COSY spectrum (600 MHz, MeOH-d4) for polysciasoside B (1)\nFigure S3. HSQC spectrum (600 MHz, MeOH-d4) for polysciasoside B (1)\nFigure S4. HMBC spectrum (600 MHz, MeOH-d4) for polysciasoside B (1)\nFigure S5. NOESY spectrum (600 MHz, MeOH-d4) for polysciasoside B (1)\nFigure S6. Selective NOESY spectrum at 1.32ppm (H-18) showing correlations to H-13, H-19 and H-15 (600 MHz, MeOH-d4) for\npolysciasoside B (1)\nFigure S7. Selective NOESY spectrum at 0.99ppm (H-19) showing correlations to H-29 and H-18 (600 MHz, MeOH-d4) for\npolysciasoside B (1)\nFigure S8. 1H NMR spectrum (600 MHz, MeOH-d4) for polysciasoside C (2)\nFigure S9. COSY spectrum (600 MHz, MeOH-d4) for polysciasoside C (2)\nFigure S10. HSQC spectrum (600 MHz, MeOH-d4) for polysciasoside C (2)\nFigure S11. HMBC spectrum (600 MHz, MeOH-d4) for polysciasoside C (2)\nFigure S12. NOESY spectrum (600 MHz, MeOH-d4) for polysciasoside C (2)\nFigure S13. 1H NMR spectrum (600 MHz, MeOH-d4) for \u03b2-hedrin (3)\nFigure S14. HRMS spectrum for polysciasoside B (1)\nFigure S15. HRMS spectrum for polysciasoside C (2)\nFigure S16. HRMS spectrum for \u03b2-hedrin\nFigure S17. Key 2D NMR correlations (600 MHz, MeOH-d4) for polysciasosides B (1) and C (2)\nFigure S18. Key NOESY correlations (600 MHz, MeOH-d4) for polysciasosides B (1) and C (2)\nFigure S19. HPLC trace (250nm) of the tolylthiocarbamoyl thiazolidine derivative of the standard sugar (D-glucose)\nFigure S20. HPLC trace (250nm) of the tolylthiocarbamoyl thiazolidine derivative of acid hydrolyzed polysciasoside C (2)"
        }
    ],
    "title": "Polysciasoside B and C: New Dammarane-type triterpene glycoside from the leaves of Australian rainforest plant Polyscias australiana (F.Muell.) Philipson (Araliaceae)",
    "year": 2023
}